Senate committee advances Saphier for surgeon general after party-line vote

Key points

• The Senate HELP Committee advanced Dr. Nicole Saphier’s nomination for surgeon general on September 30, 2026, in a 12-11 party-line vote.
• Saphier is a radiologist at Memorial Sloan Kettering Cancer Center and a former Fox News medical contributor.
• She is President Trump’s third nominee for surgeon general, following the withdrawal of Janette Nesheiwat and Casey Means.
• Saphier’s nomination advanced after she testified that the MMR vaccine is safe and does not cause autism, securing the support of Committee Chairman Bill Cassidy.
• Senator Bernie Sanders voted against the nomination, citing Saphier’s past questioning of the hepatitis B birth vaccine.

Background

The surgeon general position has been vacant for much of President Trump’s second term. His first nominee, Janette Nesheiwat, was withdrawn without explanation. His second nominee, Casey Means, a wellness influencer and ally of Health and Human Services Secretary Robert F. Kennedy Jr., faced bipartisan opposition and was ultimately withdrawn in April 2026. Saphier’s nomination was introduced in April 2026 after Means’ withdrawal. During her September 16 confirmation hearing, Saphier faced scrutiny over her vaccine stance, particularly regarding the hepatitis B birth dose and the MMR vaccine. She pledged to divest from potential conflicts of interest and stated she would follow the law if confirmed. The role of surgeon general is critical for public health messaging, and Saphier’s background as a health influencer has raised questions about the balance between evidence-based public health and digital-age credibility.

How outlets are covering it

AP News and The Washington Post reported the 12-11 party-line vote in the Senate HELP Committee, emphasizing Saphier’s advancement to the full Senate. CBS News highlighted Saphier’s testimony on vaccine safety, noting that Chairman Bill Cassidy cited her statements on the MMR vaccine as the reason for his support. MS NOW framed the nomination as part of a broader pattern of failed White House nominees, noting that even Senate Republicans have resisted some of Trump’s picks. AP News and CBS News both noted that Saphier’s stance on vaccines contrasts with the vaccine-skeptic views of Health and Human Services Secretary Robert F. Kennedy Jr. and his allies. The Washington Post emphasized that Saphier is Trump’s third nominee for the role, underscoring the difficulty in filling the position. MS NOW criticized the White House’s nominee selection process, suggesting that the Senate’s resistance to Means and Saphier reflects a limit to Republican support for unqualified or controversial picks.

Why it matters

The confirmation of a surgeon general is critical for shaping public health policy and messaging in the United States. Saphier’s nomination reflects the ongoing tension between evidence-based public health and political influences, particularly regarding vaccine policy. Her advancement to the full Senate signals a potential shift in the administration’s approach to public health, moving away from the vaccine-skeptic stance of Health and Human Services Secretary Robert F. Kennedy Jr. The outcome of her confirmation will influence public trust in health authorities and the effectiveness of public health campaigns, especially in the context of vaccine hesitancy and the role of digital influencers in health information.

What to watch

Saphier’s nomination will now be considered by the full Senate. The final vote is expected to be close, given the party-line nature of the HELP Committee vote. Senators will likely focus on her vaccine stance and her ability to balance evidence-based public health with political influences. The outcome of her confirmation will have significant implications for public health policy and messaging in the United States.